{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:34:27Z","timestamp":1784007267839,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007179","name":"Advanced Centre for Treatment, Research and Education in Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.tranon.2021.101193","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T08:39:23Z","timestamp":1628152763000},"page":"101193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Aniketh","family":"Bishnu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Dhadve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Dimri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2021.101193_bib0001","first-page":"79","article-title":"Protein-protein interactions in signaling cascades","volume":"332","author":"Mayer","year":"2006","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/jme.1.01693","article-title":"Experimental and bioinformatic approaches for interrogating protein-protein interactions to determine protein function","volume":"34","author":"Droit","year":"2005","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0003","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1006\/gyno.2000.5728","article-title":"Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer","volume":"77","author":"Konecny","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2021.101193_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/bjc.2011.469","article-title":"Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis","volume":"106","author":"Hur","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.tranon.2021.101193_bib0005","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/cncr.22601","article-title":"Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer","volume":"109","author":"Moon","year":"2007","journal-title":"Cancer"},{"issue":"5-6","key":"10.1016\/j.tranon.2021.101193_bib0006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000136802","article-title":"ATP-based chemotherapy response assay in patients with unresectable gastric cancer","volume":"73","author":"Park","year":"2007","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.tranon.2021.101193_bib0007","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ygyno.2014.02.038","article-title":"Platinum resistant\" ovarian cancer: what is it, who to treat and how to measure benefit?","volume":"133","author":"Davis","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"27","key":"10.1016\/j.tranon.2021.101193_bib0008","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.19.00194","article-title":"Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives","volume":"37","author":"Pujade-Lauraine","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.tranon.2021.101193_bib0009","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/14656566.2017.1328055","article-title":"Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies","volume":"18","author":"Tomao","year":"2017","journal-title":"Expert Opin. Pharmacother."},{"issue":"8","key":"10.1016\/j.tranon.2021.101193_bib0010","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.7314\/APJCP.2012.13.8.3973","article-title":"Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the anatolian society of medical oncology","volume":"13","author":"Kucukoner","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.tranon.2021.101193_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102505","article-title":"ERK is a pivotal player of chemo-immune-resistance in cancer","volume":"20","author":"Salaroglio","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.tranon.2021.101193_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031102","article-title":"Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.tranon.2021.101193_bib0013","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41419-020-02998-6","article-title":"PI3K\/AKT pathway as a key link modulates the multidrug resistance of cancers","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2021.101193_bib0014","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2741\/1592","article-title":"AKT\/PKB signaling mechanisms in cancer and chemoresistance","volume":"10","author":"Kim","year":"2005","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.canlet.2014.08.023","article-title":"IGF-1R inhibition potentiates cytotoxic effects of chemotherapeutic agents in early stages of chemoresistant ovarian cancer cells","volume":"354","author":"Singh","year":"2014","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0016","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41419-021-03451-y","article-title":"Molecular imaging of the kinetics of hyperactivated ERK1\/2-mediated autophagy during acquirement of chemoresistance","volume":"12","author":"Bishnu","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"1","key":"10.1016\/j.tranon.2021.101193_bib0017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13046-017-0636-8","article-title":"Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-kappaB-TNFalpha-PIK3CA loop","volume":"36","author":"Thakur","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.tranon.2021.101193_bib0018","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/138920111795163922","article-title":"The new era of bioluminescence resonance energy transfer technology","volume":"12","author":"De","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.tranon.2021.101193_bib0019","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fendo.2013.00131","article-title":"Evolution of BRET biosensors from live cell to tissue-scale in vivo imaging","volume":"4","author":"De","year":"2013","journal-title":"Front. Endocrinol."},{"issue":"8","key":"10.1016\/j.tranon.2021.101193_bib0020","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1021\/acschembio.5b00143","article-title":"NanoBRET\u2013A Novel BRET Platform for the Analysis of Protein-Protein Interactions","volume":"10","author":"Machleidt","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.tranon.2021.101193_bib0021","first-page":"321","article-title":"Dynamic monitoring of STAT3 activation in live cells using a novel STAT3 Phospho-BRET sensor","volume":"9","author":"Dimri","year":"2019","journal-title":"Am. J. Nuclear Med. Molecular Imaging"},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0022","doi-asserted-by":"crossref","first-page":"e55971","DOI":"10.1371\/journal.pone.0055971","article-title":"Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models","volume":"8","author":"Gaikwad","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.tranon.2021.101193_bib0023","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/mol.106.022616","article-title":"Analysis of G protein \u03b2\u03b3 dimer formation in live cells using multicolor bimolecular fluorescence complementation demonstrates preferences of \u03b21for particular \u03b3 subunits","volume":"70","author":"Mervine","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.tranon.2021.101193_bib0024","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.biocel.2015.02.001","article-title":"Differential activation of NF-kappaB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells","volume":"61","author":"Gaikwad","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.tranon.2021.101193_bib0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-4939-3724-0_5","article-title":"Use of BRET to Study Protein-Protein Interactions In Vitro and In Vivo","volume":"1443","author":"Dimri","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.tranon.2021.101193_bib0026","doi-asserted-by":"crossref","first-page":"e92737","DOI":"10.1371\/journal.pone.0092737","article-title":"Development of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensor","volume":"9","author":"Kuo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2021.101193_bib0027","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2013.00095","article-title":"REV, A BRET-Based Sensor of ERK Activity","volume":"4","author":"Xu","year":"2013","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112313","article-title":"Noncanonical pS727 post translational modification dictates major STAT3 activation and downstream functions in breast cancer","volume":"396","author":"Dimri","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"7","key":"10.1016\/j.tranon.2021.101193_bib0029","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2021.101193_bib0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1476-4598-11-84","article-title":"Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1\/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis","volume":"11","author":"Goncharenko-Khaider","year":"2012","journal-title":"Mol. Cancer"},{"issue":"45","key":"10.1016\/j.tranon.2021.101193_bib0031","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1038\/sj.onc.1209643","article-title":"Hypoxia-inducible factor-1\u03b1 expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas","volume":"25","author":"Gort","year":"2006","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.tranon.2021.101193_bib0032","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/mc.22205","article-title":"Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability","volume":"54","author":"Ali","year":"2015","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.tranon.2021.101193_bib0033","doi-asserted-by":"crossref","first-page":"36612","DOI":"10.1038\/srep36612","article-title":"An active IGF-1R-AKT signaling imparts functional heterogeneity in ovarian CSC population","volume":"6","author":"Singh","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2021.101193_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-03451-y","article-title":"Molecular Imaging of the kinetics of hyperactivated ERK1\/2 mediated autophagy during acquirement of chemoresistance","author":"Bishnu","year":"2021","journal-title":"Cell Death and Disease"},{"issue":"28","key":"10.1016\/j.tranon.2021.101193_bib0035","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24884","article-title":"Cisplatin-induced ERK1\/2 activity promotes G1 to S phase progression which leads to chemoresistance of ovarian cancer cells","volume":"9","author":"Kielbik","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.tranon.2021.101193_bib0036","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11033-016-3943-9","article-title":"Extracellular signal-regulated kinase 1 and 2 in cancer therapy: a focus on hepatocellular carcinoma","volume":"43","author":"Mehdizadeh","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.tranon.2021.101193_bib0037","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1186\/1471-2407-13-549","article-title":"Identification of the IGF1\/PI3K\/NF kappaB\/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer","volume":"13","author":"Koti","year":"2013","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.tranon.2021.101193_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093233","article-title":"Mechanisms of Multidrug Resistance in Cancer Chemotherapy","volume":"21","author":"Bukowski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2021.101193_bib0039","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13048-016-0278-z","article-title":"Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines","volume":"9","author":"Januchowski","year":"2016","journal-title":"J. Ovarian Res."},{"issue":"19","key":"10.1016\/j.tranon.2021.101193_bib0040","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.3748\/wjg.14.3064","article-title":"Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experience","volume":"14","author":"Wu","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.tranon.2021.101193_bib0041","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/15384047.2014.987062","article-title":"Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway","volume":"16","author":"Chen","year":"2015","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.tranon.2021.101193_bib0042","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/ar.22552","article-title":"Reversal of multidrug resistance by gefitinib via RAF1\/ERK pathway in pancreatic cancer cell line","volume":"295","author":"Xiao","year":"2012","journal-title":"Anat. Rec."},{"issue":"12","key":"10.1016\/j.tranon.2021.101193_bib0043","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3748\/wjg.15.1443","article-title":"Down-regulation of extracellular signal-regulated kinase 1\/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells","volume":"15","author":"Yan","year":"2009","journal-title":"World J. Gastroenterol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523321001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:20:15Z","timestamp":1761844815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523321001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1936523321001856"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101193","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2021.101193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101193"}}